A major advance in cancer investigation is arising with the use of nanobodies to reactivate mutated p53. This essential tumor suppressor protein is frequently disabled in several forms of cancer, causing uncontrolled https://bookmarkgenius.com/story21807373/mini-antibodies-revive-tumor-suppressor-p53-a-potential-pathway-for-cancer-therapy